BCL2 and cancer: The interplay between ERBB2 and its direct targets MYC, PTEN, and BCL2 creates a robust network that collaboratively impacts cancer cell biology by promoting proliferative signaling, evading growth suppressors, resisting cell death, and facilitating invasion and metastasis.